Beclate Inhaler

Developed to manage persistent asthma to alleviate airway inflammation.

Strengths: 200mcg

Medicine details

Conditions
Alternative names

Clenil Modulite; Beclomet Easyhaler

Therapeutic class

Inhaled Corticosteroid

Pharmacological class

Corticosteroid

Contraindications

hypersensitivity to beclometasone

Minor side effects

hoarseness; throat irritation

Moderate side effects

oral candidiasis; cough

Serious side effects

paradoxical bronchospasm — requires immediate medical attention

Dosage forms

Pressurised inhalation, suspension

Administration route

Inhalation use

Patient summary

Developed to manage persistent asthma to alleviate airway inflammation.

Prescription status

POM

Manufacturer

Chiesi

Onset Time

several days

Duration

constant control

Storage instructions

Store below 30°C.

Age restrictions

Use as prescribed by age group.

Pregnancy and breastfeeding

Consult your doctor during pregnancy.

Precautions and warnings

rinse mouth after use; regular use essential for efficacy; check inhaler technique

Mechanism of action

Beclomethasone acts as a potent anti-inflammatory corticosteroid that reduces airway hypersensitivity and swelling, improving respiratory function.

Beclate Inhaler

Developed to manage persistent asthma to alleviate airway inflammation.

Editorial Notes

  • Active ingredient(s): Beclomethasone
  • Listed indication(s): Asthma

Available option

  • 3 inhalers - 200 mcg348-200-mcg-18233